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Abstract 
Increased reactivity to stress is observed in patients with schizophrenia spectrum disorders and their healthy siblings in comparison to the general population. 
Additionally, higher levels of neuroticism, as a proposed psychological measure of stress sensitivity, increasethe risk for schizophrenia. HPA axis dysregulation 
is one of the possible mechanisms related to the vulnerability-stress model of schizophrenia and recent studies revealed a possible role of the functional genetic 
variants of FK506-binding protein 51 (FKBP5) gene which modulate activity of HPA axis. 
The purpose of the present study was to investigate impact of FKBP5 on schizophrenia in Serbian patients, and to explore relationship between genetic variants 
and neuroticism by using the case-sibling-control design. In 158 subjects we measured psychotic experiences, childhood trauma and neuroticism. Nine single 
nucleotide polymorphisms (rs9295158, rs3800373, rs9740080, rs737054, rs6926133, rs9380529, rs9394314, rs2766533, rs12200498) were genotyped. The 
genetic influence was modeled using logistic regression, and the relationship between genetic variants and neuroticism was assessed by linear mixed model. Our 
results revealed genetic main effect of FKBP5 risk alleles (A allele of rs9296158 and T allele of rs3800373) and AGTC “risk” haplotype combination 
(rs9296158, rs3800373, rs9470080, rs737054, respectively) on schizophrenia, particularly when childhood trauma was set as a confounding factor. We 
confirmed strong relationship between neuroticism and psychotic experiences in patients and siblings and further showed relationship between higher levels of 
neuroticism and FKBP5 risk variants suggesting potential link between biological and psychosocial risk factors. Our data support previous findings that trauma 
exposure shapes FKBP5 impact on schizophrenia. 
Keywords: schizophrenia, healthy siblings, FKBP5 genetic variants, haplotypes, neuroticism 
Introduction 
The vulnerability-stress model has long been proposed as an important framework for the study of etiology and clinical courseof all major psychiatric disorders 
including schizophrenia and related psychotic disorders [1-3]. The model offered substantial evidence that schizophrenia isa stress-sensitive disorder and 
highlighted increased interpersonal sensitivity to environmental stressors in patients [4]. Regarding this hypothesis, several lines of evidence indicated that major 
neurobiological mechanism for vulnerability-stress model present the hypothalamic-pituitary-adrenal (HPA)axisdysregulation found across the illness course[5]. 
Blunted cortisol awaking response is consistently reported in drug-naive patients [6, 7], ultra-highrisk group for psychosis [8], andalso in converters to 
psychosis[9]. Elevated basal cortisol levelswerepresent in the different phases of schizophrenia, associated with symptoms severity and cognitive functioning [10, 
11], while theresults derived from the post-mortem tissue of patients with schizophrenia revealed decreased mRNA expression of the glucocorticoid receptor 
(GR), the primary receptor responsive to cortisol and thus stress response[12]. Regarding hyperdopaminergic activity in the mezolimbic area observed in 
schizophrenia, it is suggested that HPA axis triggers a cascade of events resulting GR impairment and potential to increase activity of dopamine pathway 
involved in schizophrenia and related psychotic disorders [13].   
The pivotal role in the regulation of GR activity hasa co-chaperone FK-506 binding protein 51 (FKBP51) which modulates GR sensitivity to cortisol [14]. Higher 
expression of FKBP51 leads to an altered GR responsiveness to cortisol and thus impaired regulation of the HPA axis negative feedback loop [15]. FKBP5 gene, 
located on the chromosome 6p21, encodes this important protein. According to the consistent evidence, FKBP5 comprises several functional single nucleotide 
polymorphisms (SNPs), such as rs1360780, rs9296158, rs3800373 and rs9470080,which genotypes containing minor allele (T, A, G, T, respectively) are related 
to the increased FKBP5 expression[16] and thus impaired HPA axis negative feedback loop[17] as well as to allele-specific FKBP5 epigenetic changes[18]after 
stress exposure . Particularly, these genetic variations determining expression of FKBP51 may explain higher sensitivity to trauma. Genotypes of these functional 
SNPs with minor (risk) allele have been consistently associated with broad range of stress-related psychiatric disorders such as PTSD, depression, bipolar 
disorder, borderline personality disorder [16-21] and pathological conditions (suicide, aggressive behavior) following trauma exposure [22, 23].The first evidence 
for the role of FKBP5 ina non-affective psychosis was reported by Collip and colleagues [24], revealing significant effect of the interaction between risk alleles 
and childhood trauma on psychotic symptoms. Alongside with the clinical population, given interaction was found at the subclinical level of psychotic 
symptoms, by evaluation of patients’ healthy siblings and controls. After this publication, several studies confirmed the association between FKBP5risk alleles 
and psychosis in individuals that reported stressful environmental exposure [25, 26], moderating cognitive impairment [27] as well as their different response to 
clozapine [28]. In addition, FKBP5 mRNA levels were shown to be increased in the postmortem tissues of patients with schizophrenia [29, 30]. Regarding these 
evidences, recent review proposed the role of FKBP5 gene for vulnerability-stress model of schizophrenia related to gene-stress interaction [31].  
The vulnerability-stress model also emphasizes important role of psychosocial risk factors in the etiology of schizophrenia. It is well established that personality 
trait neuroticism could be considered as a psychosocial risk factor as it is characterized by chronic negative affect and susceptibility to stress (distress proneness). 
Studies confirmed that young individuals with higher neuroticism have increased risk for later schizophrenia [32-34] and that this trait has been associated with 
psychotic symptoms severity [35] as well as patients’ functional outcomes [36].Interestingly, Boyette and colleagues revealed stronger association between 
neuroticism and psychotic symptoms in patients with psychosis and their healthy siblings compared to controls [37]. These findings are related to an increased 
stress sensitivity observed in patients and their healthy siblings, which suggest that altered stress-sensitivity should be considered as a familial risk for psychosis 
[38, 39]. Particularly, larger increase of negative affect in relation to stress has been found in patients and their siblings compared to controls [40]. Higher levels 
of neuroticism lead to more negative affect experiences and more sensitive response to environmental stressors which is exactly what vulnerability-stress model 
postulate. It is also suggested that the systems involved in adaptation, such as HPA axis, could play an important role in the neurobiological pathway of 
neuroticism [41]. In addition, recent study revealed strong correlation between negative affect and higher expression of FKBP51protein level suggesting potential 
biological explanation of interplay between neuroticism, as a measure of proneness to negative affectivity, and increased stress sensitivity [42]. 
The purpose of the present study was to analyze biological (FKBP5 genetic variants) and psychosocial (neuroticism) risk factors and their interrelationship as a 
pathway of altered stress reactivity proposed by vulnerability-stress model of schizophrenia. Regarding consistent evidence ofFKBP5 role in the stress-related 
disorders, including schizophrenia, we hypothesized thatin Serbian sample FKBP5risk variants would have an impact on patients' status following trauma 
exposure and, due to increased stress-sensitivity reported in healthy siblings, different distribution of FKBP5 risk variants between siblings and controls could be 
found. In conjunction with the findings that increased FKBP51 expression strongly correlates with negative affectivity, we hypothesized that neuroticism could 
be associated with risk ("high induction") allele carriers ofFKBP5 functional  SNPs. Accordingly, the first objective of the present study was to investigate 
differences in genotype, allele and haplotype distribution of FKBP5 genetic variants among patients, their healthy siblings and controls. In addition, we examined 
the genetic main effects on patients' status taking into account childhood trauma as a confounding factor. The second objective of the research was to replicate 
the findings of Boyette and colleagues [37], showing stronger association between neuroticism and psychotic experience in patients and siblings compared to 
controls, and to further investigate relationship between neuroticism and potential biological risk factors such as specific FKBP5variants. 
Materials & Methods 
Participants  
The data collection was conducted in Serbia, as a part of the European Network of National Networks studying Gene-Environment Interactions in Schizophrenia 
(EUGEI) [43]. In this cross-sectional study, the sample comprised of 52 patients within schizophrenia spectrum disorders, 55 of their healthy siblings (first-
degree relatives), and 51 healthy controls. Patients were selected by clinicians from two regional mental health institutions from Belgrade and surrounding 
(University Psychiatric Clinic in Belgrade and Special Psychiatric Hospital in Kovin). Healthy siblings were sampled through participation of the patients, and 
controls were included through a local advertisement. Inclusion criteria for the patients were (I) age range 18-40, (II) IQ >70, (III) meeting DSM-IV [44] criteria 
for schizophrenia spectrum disorders, not caused by neurological disorder or substance abuse assessed by Mini International Neuropsychiatric Interview(MINI 
5.0.0)[45], (IV) maximum duration of illness <10 years, (V) remission status (GAF scores >40) [46]. Siblings and controls had no evidence of current/past 
history of psychiatric disorder and no recent history of alcohol or drug abuse as verified by MINI.For the controls, the occurrence of psychotic disorder in any 
first-degree family member, assessed using the Family Interview for Genetic Studies (FIGS) [47], was constituted as an exclusion criterion. The control 
participants were matched by age and gender with sibling participant.  
After full explanation of the study, all participants agreed to participate and written informed consent was obtained. The research was performed in compliance 
with the International Code of Medical Ethics of the World Medical Association (Declaration of Helsinki) and was approved by the appropriate hospitals' ethics 
committee and Ethics Committee of Faculty of Medicine, University of Belgrade. 
Phenotype and confounding measures 
Psychotic experiences 
We used the Community Assessment of Psychic Experiences to rate self-reports of psychotic experiences. The CAPE measures the life time prevalence of the 
subclinical positive, negative and depressive symptoms as well as a distress related to the symptoms [48]. It provides a total score per these three dimensions by 
adding up the scores on the frequency items. Items are scored on a 4-point scale. Studies using CAPE in the general population have shown good psychometric 
properties in terms of reliability and validity [49]. It is used to assess subclinical psychotic symptoms on the psychosis continuum, as a clinical and extended 
psychosis phenotype [36, 50]. For the purposes of the present study, we included standardized sum scores of the subscale (score range 1-4) for positive symptoms 
(CAPE-P) and depressive symptoms (CAPE-D) in the further analyses.  
Neuroticism 
All participants were asked to fulfill a 30-item scale extracted from the Eysenck Personality Questionnaire (EPQ-103) which was measuring personality trait 
neuroticism [51]. Neuroticism is a very well established measure of distress proneness, increased sensitivity to stress, and tendency to experience more overall 
psychopathology. Higher levels of neuroticism reﬂect increased self-referential evaluation of negatively valence stimuli. It is confirmed that neuroticism is 
influenced by substantial genetic background [41]. Studies in schizophrenia patients reported stability of personality traits over time, but recent study suggested 
that depressive symptoms could have a strong influence on personality traits stability after three years of follow-up [52]. Thus, we included in our phenotype 
analyses CAPE-D as a covariate. Participants completed EPQ neuroticism (EPQ-N) on the same day when testing was performed.  
Childhood trauma  
Childhood adversities were measured by the Childhood Trauma Questionnaire (CTQ) [53]. It is a retrospective self-report questionnaire, consisting of 25 items 
rated on a 5-point Likert scale (1=never true, 5=very often true). CTQ is one of the most frequently used scales assessing childhood advertises related to different 
psychopathology as well as psychotic disorders [24, 36], with well confirmed validity and reliability in the general population[53]. It is measuring five types of 
childhood trauma: emotional abuse, physical abuse, emotional neglect, physical neglect and sexual abuse. Each domain of trauma severity is ranging from 1 to 5. 
Consistent with previous literature, we summed the mean score for all 25 items (CTQ-total) to obtain a continuous measure of CTQ symptoms severity (score 
range 1-5).  
 Genetic data  
DNA extraction, SNP Genotyping 
All participants included in this study were Caucasians, of the same Serbian ethnicity, with former Yugoslavian origins confirmed using FIGS. DNA was 
extracted from EDTA-treated whole blood using the salting-out method [54]. Genotyping for rs9296158 was performed using TaqManallelic discrimination 
assay [55] on the ABI 7900HT (Applied Biosystems, Foster City, CA, USA). Genotyping for rs3800373, rs9740080, rs737054, rs6926133, rs9380529, 
rs9394314, rs2766533, rs12200498 were performed on the Illumina’s Infinium platform using IPMCN chip (Institute of Psychological Medicine and Clinical 
Neurology, Cardiff University) custom-made for EUGEI sample [43]. Genotype data passed quality control, with call rate > 98% for all polymorphisms. A total 
of nine SNPs were included in genetic analyses for the genotype distribution, allele and haplotype frequencies. After these evaluations, for the association 
analyses we selected three SNPs (rs3800373, rs9470080, rs9296158) on the basis of their functional significance confirmed in the literature that we explained in 
the introduction.  
Hapotype analysis 
Hardy–Weinberg equilibrium (HWE), pairwise linkage disequilibrium (LD) (D′ and r2 values) and minor allele/haplotype frequencies of SNPs were computed 
using the Haploview software, version 4.2 [56]. Chromosomal position, allelic distribution, HWE and role of all genotyped FKBP5 SNPs are presented in the 
Table S1 (see Supplementary Materials). All of the analyzed SNPs were in Hardy–Weinberg equilibrium concordance, first examined for all participants taken 
together and then for each group separately. "Solid spine block" definition was used for haplotype block identification, following "solid-spine" criteria D' ≥ 0.80. 
Permutation testing to calculate corrected p values for multiple testing of 1,000 simulations was performed using Haploview software. Linkage disequilibrium 
plots, with D' among analyzed SNPs presented within groups and haplotypes frequencies (patients vs. controls/ siblings vs. controls) are presented in the Figure 
1. Haploview computed two haploblocks, one consisted of four SNPs including three functional SNPs (rs3800373, rs9296158, rs9470080) and rs737054, and the 
other one consisted of five SNPs (rs6926133, rs9380529, rs9394314, rs2766533 and rs12200498). Based on the previous research [57], haplotype combination 
comprised of minor “risk” alleles (AGTC) and presented with one or two copies were grouped together and assigned as group '1', thus individuals with zero 
copies of this haplotype were assigned as group '0'. This dichotomous variable was utilized in subsequent analyses to examine main effect on patients' status and 
phenotype. 
Statistical analysis  
Data were analyzed using the SPSS software, version 20.00 (SPSS, Chicago, IL, USA). Data are presented as counts (percents), mean ± standard deviations or 
median (range), depending on data type and distribution. Between group differences in demographic characteristics (age and gender), phenotype measures 
(CAPE-P, EPQ-N) and confounding factors (CTQ-total, CAPE-D) were assessed using chi-square and Kruskal-Wallis test. Bonferroni adjustment was applied 
for multiple comparison. 
Genetic analyses 
First objective of the study was to compare genotype distribution and allele frequencies among the groups, for which contingency tables and the chi-square test 
were used. The two tailed Pearson X2was performed for 2x2 contingency tables to compare genotypes frequenciesbetween the groups (patients vs. controls/ 
siblings vs. controls). Fisher's Exact Test was used for 2x2 contingency tables to compare allele and AGTC haplotype frequencies among the groups (patients vs. 
controls/siblings vs. controls).Bonferroni correction for multiple comparison was applied setting statistical significance threshold (α) at 0.025.Further, we 
performed a binary logistic regression analyses to assess the genotype and allele association with patients’ status. We usedgeneral (AA as a reference genotype: 
AA vs. Aa/AA vs. aa), dominant (Aa+aa vs. AA) and recessive (AA+Aa vs. aa) genetic model. Additionally, we performed the logistic regression to asses 
AGTC haplotype association with patients' status. All genetic main effects were analyzed in three models using OR (odds ratio) with 95% confidence interval 
(95%CI) as a measure of effect. First we preformed unadjusted analyses (Model 1), then we made adjustments for age, gender and depressive symptoms (Model 
2) as previously suggested due to FKBP5 effects on depression phenotype [24], and in the third model we added childhood trauma as a confounding factors 
(Model 3). We preformed GxE interactions in the last set of the analyses, accounting genetic data as a dichotomous variable (risk allele carries vs. no-risk allele 
carriers). We did not correct our results for multiple testing as our SNPs are in high LD and regarding previous substantial evidence reported in the literature of 
their biological significance and influence on different psychopathology.  
Phenotype analyses 
According to the second objective of the present study, Spearman's Rho correlations and linear regression were used to analyze relationship between EPQ-N and 
CAPE-P. Further on, as we were particularly focused on neuroticism as a psychosocial risk factor, we utilized rigorous statistical method to assess the effect of 
SNPs/AGTC haplotype on neuroticism, performing in all participants and healthy individuals separately. For that purpose we used the linear mixed model. EPQ-
N was transformed with square root transformation and set as an outcome variable. SNPs/AGTC haplotype were separately included in the model as a categorical 
variable ('0' - non risk allele carriers, '1' - risk allele carriers / '0' - zero copies of AGTC haplotype, '1' - 1 or 2 copies of AGTC haplotype, respectively). Analyses 
were controlled for several potential confounders: age, gender, group status, and CAPE-D. Intra-family correlation (Family ID) was set as a random factor as 
previously described [37]. Phenotype analyses were first performed for all participants and then only for healthy participants (sibling and controls). All reported p 
values were two-sided and considered as significant if less than 0.05. 
Results 
Description of the sample, phenotype and confounding measures 
Main characteristics of all participants are presented in the Table 1. No differences between the groups in terms of demographic characteristics were observed. 
Patients reported significantly higher levels of phenotypic characteristics (CAPE-P, CAPE-D, and EPQ-N) compared to siblings (p0.001) and controls 
(p<0.001), respectively. Patients experienced more trauma in childhood (CTQ-total) compared to controls (p=0.003), while no differences in trauma levels were 
evident between patients and siblings (p=0.264), and between siblings and controls (p=0.305). 
Table 1 
Association between neuroticism and psychotic experiences among the groups 
Spearman's Rho correlations revealed that CAPE-P correlated strongly with EPQ-N in patients (r=0.583, p<0.001) and siblings (r=0.339, p=0.013), whereas no 
significant correlation was observed in the control group (r=0.204, p=0.231). The liner regression analysis (Table 2) confirmed the association between 
neuroticism and psychotic experiences in patients (b=0.301, p<0.001) and siblings (b=0.252, p=0.003) and, as expected, no significant association was found in 
the control group (b=0.035, p=0.224). Also, strong correlation between CAPE-D and EPQ-N in patients (r=0.732, p<0.001), siblings (r=0.434, p=0.001) and 
controls (r=0.595, p<0.001) was detected, thus CAPE-D was set as a confounding factor in the genetic and phenotype analyses.   
Table 2 
Genotype distribution and allele frequencies  
Genotype distribution and allele frequencies of the studied functional SNPs (rs9296158, rs3800373, and rs9470080) are presented in the Table S2 (see 
Supplementary Materials). Among all studied SNPs there was a trend in genotype distribution between patients and controls only for rs380373 (p=0.041). 
Regarding the allele frequencies, differences between patients and controls were evident for minor "risk" allele of rs3800373 (G allele:37.5% vs. 22.5%, 
respectively; p=0.020), while trend was found for risk allele of rs9296158 (A allele: 43.1% vs. 30.0%, respectively; p=0.053). There were no differences in the 
aforementioned functional SNPs comparing sibling vs. controls. Differences between groups in genotype distribution and allele frequencies among other SNPs 
(rs737054, rs6926133, rs9380529, rs9394314, rs2766533, rs12200498) were not observed. 
Haplotype frequencies  
Haploview generated two haploblocks (Figure 1).First block contained three functional SNPs (rs9296158, rs3800373, rs9470080) and rs737054. Around 90% of 
participants in the first block were presented with GTCC, AGTC, or GTCT haplotype. AGTC haplotype comprised of three "risk" alleles (A, G, T, respectively) 
presented “risk” haplotype. Our results showed that AGTC haplotype was significantly more frequent in patients compared to controls (35.5% vs. 21.3%, 
p=0.026).  GTCC haplotype, with no "risk" alleles, and thus observed as “non-risk” haplotype tended to be more frequent in controls compared to patients 
(42.8% vs. 29.7%, p=0.053) and siblings (42.8% vs. 29.1%, p=0.038), respectively. Further, there was a tendency that GTCT haplotype (with no "risk" alleles), 
also observed as “non-risk” haplotype, was more present in siblings compared to controls (35.4% vs. 22.4%, p=0.054). In the second block  GTCTC, GTTCC, 
TTCCC haplotypes tended to be more frequent in siblings compared to controls (p=0.076, p=0.074, p=0.064, respectively), but taken together these blocks were 
presented in around 15% of participants. Differences in the second block between patients vs. controls were not found. After calculation of corrected p values 
obtained after 1,000 permutations, observed differences in the distribution were not significant. In addition to haplotype analyses and following haplotype 
assignment, individuals with one or two copies of AGTC “risk” haplotype were grouped together (group '1') and compared to individuals with zero copies of this 
haplotype(group '0'). Group '1' was more frequent in patients compared to controls (64.7% vs. 35.4%, respectively; p=0.005) while siblings were in intermediate 
position regarding AGTC haplotype (Table S3, Supplementary Materials). 
Figure 1  
Association analyses between functional SNPs/AGTC haplotype and schizophrenia  
Major findings of case-control association analyses between functional SNPs/AGTC haplotype and schizophrenia are presented in the Table 3.The logistic 
regression revealed strong genetic main effect under the dominant genetic model for rs3800373 (TG+GG vs. TT), showing strong impact of “risk” G allele 
carriers on patients' status under unadjusted model (OR=2.742; p=0.014), with the pattern of “increasing risk” after including childhood trauma into the model 
(OR=4.261, p=0.004).The general genetic model for rs3800373 is presented in Table S3 (see Supplementary Materials). Results of the unadjusted logistic 
regression showed that heterozygous TG of rs3800373, with "risk" G allele, was associated with increased risk for schizophrenia spectrum disorders compared to 
homozygous TT (OR = 2.644; p=0.032). After adjusting, analyses yielded the same pattern in the second and particularly in the third model, where childhood 
trauma was included as a confounding factor(OR = 3.662; p=0.008). Additionally, after accounting childhood trauma, homozygous for "risk" G allele (GG) was 
strongly associated with increased risk for schizophrenia compared to homozygous TT (OR=8.561; p=0.027).  
The similar pattern of the association was observed for rs9296158. Homozygous for "risk" A allele increased the risk for schizophrenia compared to carriers of 
GG genotype after taken into account childhood trauma (OR=6.738; p=0.030) (Table S3, Supplementary Materials). Following "risk" A allele contribution, the 
dominant genetic model (GA+AA vs. GG) showed borderline significance on patients' status particularly after adjusting for childhood trauma (OR=2.687; 
p=0.052) (Table 3). The general genetic model of rs9470080 revealed strong effect of homozygous for "risk" T allele compared to homozygous CC only after 
adjusting for childhood trauma (Table S3, Supplementary Materials) (OR=5.006; p=0.044). Regarding “risk” AGTC haplotype, the logistic regression presented 
in the Table 3 revealed that AGTC haplotype carriers have increased risk of developing schizophrenia compared to individuals with no copies of this haplotype 
in unadjusted analysis (OR = 3.343,  p=0.004), whereas the risk for developing schizophrenia increased after adjustment for childhood trauma (OR = 5.191, 
p=0.002). GxE interactions were not detected (Table S4, Supplementary Materials).  
Table 3 
Association between neuroticism and the functional SNPs/AGTC haplotype 
In the whole sample analysis, a strong association between risk allele carriers of the functional SNPs/risk AGTC haplotype with higher levels of neuroticism was 
found (Table 4). Analysis of the whole sample, revealed that risk allele of rs9296158 (b=0.338, p=0.003), rs3800373 (b=0.320, p=0.006), rs9470080 (b=0.317, 
p=0.006) and AGTC haplotype combination (b=0.342, p=0.004) were strong predictors of the higher levels of neuroticism, controlling for age, gender, group 
status, intra-family relationship and CAPE-D. After focusing on the non-clinical population only (patients were excluded), results were conclusive with previous, 
confirming that risk allele of rs9296158 (b=0.293, p=0.029), rs3800373 (b=0.306, p=0.025), rs9470080 (b=0.295, p=0.030) and AGTC haplotype combination 
(b=0.310, p=0.027) were strong predictors of higher neuroticism.  
Table 4 
Discussion  
The results of the present study supported vulnerability-stress model for schizophrenia and hypothesis of increased stress-sensitivity reported in patients and their 
healthy siblings. We systematically presented three lines of evidence: 1) we confirmed genetic main effect of FKBP5 risk alleles on presence of schizophrenia 
particularly after including childhood trauma as a confounding factor, highlighting the importance of accounting exposures to environmental stressors in genetic 
studies; 2) we revealed for the first time higher frequencies of  “risk” haplotype in patients and higher frequencies of “non-risk” haplotype in healthy siblings and 
controls; and 3) we confirmed a strong relationship between neuroticism and psychotic experiences in patients and siblings as similar toBoyette et al. study [37] 
and we further found significant association between risk allele carriers/risk haplotype and higher neuroticism, suggesting a potential psychosocial inherited risk 
phenotype for schizophrenia related to vulnerability-stress hypothesis.  
Firstly, our results revealed an increased risk for schizophrenia under the dominant genetic model for rs3800373 and rs9296158, showing strong genetic 
influence of their risk alleles (G and A, respectively) on the disease particularly after accounting for childhood trauma. Previous findings from the literature 
suggested that FKBP5 risk variants contribute to psychosis risk only in the presence of specific environmental risk factors. For example, Collip et al. [24] 
presented evidence of GxE interaction impact on the psychotic symptoms across psychosis continuum, whereas environmental risk factor was childhood trauma 
and genetic risk variants were risk A allele carriers of rs9296158 and rs471396. Similarly, we observed increased genetic impact of risk A allele of rs9296158 on 
schizophrenia when we included childhood trauma as the confounding factor. We did not observe GxE interaction probably because our childhood trauma scores 
in patients were lower than reported in their study (in our sample CTQ-total mean score was1.4, while Dutch sample had CTQ-total mean score 1.7).On the other 
hand, Ajnakina et al. highlighted genetic main effect on the presence of psychotic disorder but only after including environmental exposures as confounding 
factors [25]. In their study different environmental risk factors were set as confounding factors under the dominant genetic model for rs1360780, showing strong 
genetic effect of the risk T allele after accounting for parental separation and cannabis use. Our results under the dominant genetic model for rs3800373 are in 
line with the results of Ajnakina and colleagues. Specifically, our unadjusted genetic main effect and confidence interval of risk G allele carriers of rs3800373 
(OR=2.74, 95%CI: 1.22 to 6.14, p=0.014) were very similar to their adjusted genetic main effect of risk T allele carriers of rs1360780 (OR=2.81, 95%CI: 1.23 to 
6.43, p=0.002).Consistently, we observed that the risk for schizophrenia increased when childhood trauma was included as a confounding factor into the model 
(OR=4.26, p=0.004). In addition, we controlled association analyses for depressive symptoms to avoid the limitation reported in their study, and it did not alter 
the observed effect. Similar results between the research groups are expected as our analyzed SNPs are consistently reported in the strong LD with rs1360780 
[16-18].Beside these findings in psychosis, several other research lines have shown genetic influence of risk G allele for rs3800373 and risk A allele for 
rs9296158, following childhood trauma exposure, on the development of PTSD and depression [16, 17, 19]. 
To the best of our knowledge this is the first study that preformed FKBP5 haplotype analysis in schizophrenia patients and their healthy siblings compared to 
controls. However due to the small sample size it should be considered as a pilot study. We observed that AGTC haplotype with three risk alleles (AGT), and 
assigned as a risk haplotype also in the literature [57, 58],was more frequent in patients compared to controls. GTCT haplotype (with no-risk alleles) was more 
frequent in controls either when we compared to patients or to siblings. Interestingly, GTCC haplotype,also comprised of no-risk alleles, was more frequent in 
siblings compared to controls. After performing permutation analysis, as a more conservative method, haplotype differences did not remain significant. This 
could be due to the sample size rather than false positive results, because our results are consistent with the previous findings. Studies showed that FKBP5 
haplotype comprised of risk alleles for functional SNPs (rs9296158, rs3800373, rs1360780, rs9470080) had strong influence in interaction with trauma on stress-
related psychiatric disorders [20, 57, 58]. Indeed, we found strong impact of FKBP5 risk haplotype on schizophrenia, with increased influence when we 
accounted childhood trauma.Same studies suggested that individuals with no-risk alleles in the haplotype had protective effect related to stress conditions. This 
could be one of the explanations of higher non-risk haplotype frequencies in the controls and siblings in our sample as a potential protective or resilient biological 
mechanism. 
Our phenotype analyses revealed similar results to the observation of Boyette et al. [37], confirming strong association between neuroticism and psychotic 
experiences in patients and their siblings. Although we did not observe this association in the control group, possibly due to the limited sample size, we have 
shown the same pattern of “increasing association” between neuroticism and psychotic experiences in the control-sibling-patient direction. Furthermore, we 
found strong association between risk allele carriers of all three functional SNPs /risk AGTC haplotype and neuroticism as a phenotype of distress-proneness. 
Both findings could be linked to the reported evidence of increased stress-sensitivity in the first degree relatives of patients with psychosis, suggesting an 
inherited pathway and genetic influence on higher sensitivity to stress [59]. Additionally, recent studies revealed that the functional consequence of the 
interaction between risk haplotype comprised of the risk alleles of functional SNPs (rs9296158, rs3800373, rs9470080 and rs1360780) and trauma are limbic 
irritability and an increased amygdale activity [57, 58]. Since the aforementioned regions are crucial for emotional functioning, their impairment could lead to 
anxiety, distress, and negative emotional processing that actually describes neuroticism as a phenotype and support our findings. 
We would like to point out several limitations of the study. We did not have genotype data for rs1360780, as one of the promising risk markers for FKBP5related 
psychopathology, which could give us more information about the overall genetic impact. We did not measure some other biological data such as cortisol levels, 
mRNA expression or epigenetic changes of FKBP5, which could provide us deeper insight into regulatory nature of FKBP5 neurobiological pathway. Although 
the observed genetic associations with schizophrenia could be considered weak due to the small sample size, our results are exactly in line with the previous 
findings regarding FKBP5 association with psychosis and stress related psychiatric disorders. Further, we would like to emphasize that an interpretation of the 
strong genetic main effect, even under unadjusted analyses, in the Serbian patients’ sample could be due to the overall stressful environment over the decades in 
this region. The "three-hit" hypothesis of vulnerability model suggests cumulative stress impact on psychiatric disorders [60]. War, sanctions and low economy 
over a decade in our country could present chronic cumulative stress exposure and risk factors particularly for individuals with the genetic predisposition for 
systemic changes in the HPA axis activity. Importantly, this stressful period was in time of the childhood and puberty of our participants which is suggested as a 
critical period for HPA axis disturbance sinceFKBP5 mRNA expression increases particularly during this time of the development [61]. The recent study did not 
find association between anxiety in adolescence and FKBP5 risk variants, but the reason actually could be lack of traumatic life events in their analyses [62]. 
Based on the concept of allostasis, stressful environment may disrupt functioning during sensitive period and contribute to the development of allostatic overload. 
Thus, prolonged stress results in dysregulation of HPA axis, leading to inefficient homeostasis and stress-related disorders [63]. Genetic vulnerability (such as 
risk FKBP5 variants) prior to the trauma exposure could influence stress sensitivity by modulating homeostatic elements in the stress cascade which is actually 
one of the neurobiological hypothesis for vulnerability-stress model of schizophrenia [5].  
Conclusion 
Altered sensitivity to the stressful environment makes adaptation a difficult process, leading to a higher susceptibility to stress and proneness to psychopathology. 
Our findings confirmed the role of FKBP5 gene in patients with psychosis exposed to trauma, serving as a basis to further evaluate etiologically similar subgroup 
of “schizophrenias” applicable for vulnerability-stress model. Additionally, our study results support previous findings that environmental stressors are warrant 
for shaping FKBP5 effect in psychotic disorders. Regarding overall FKBP5 research, its impact is observed in different stress-related psychiatric disorders which 
suggest importance of consideration for a similar stress-related pathway across diagnostic boundaries. The ability to discriminate high risk and resilience group 
under the stress-related biological pathway and to find an intermediate phenotype could be important framework for developing strategies of psychosis 
prevention and early intervention trough the personalized approach.  
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Figure 1. Linkage disequilibrium (LD) plots and distribution of FKBP5 haplotypes in the analyzed sample.The values within each square represent pair-wise 
linkage disequilibrium (D'). Box colors correspond as follows: Red- LOD>2, D’=1; Shades of pink- LOD>2, D’<1; Blue-LOD<2, D’=1, White- LOD<2, D’<1. 
a) LD plots for patient and control group taken together (on the left) anddistribution of identified haplotypes (on the right) b) LD plots for sibling and control 
group taken together (on the left)anddistribution of identified haplotypes (on the right).Presented p values are uncorrected and with performing permutation 
analyses;P<0.05 are presented in bold, P<0.1 are presented in italic 
 
 
 
Haplotypes Total Patients Controls 
 
P value 
Permutation 
P value 
 
  % % % 
 
 
Block 1 
GTCC 36.0 29.7 42.8 0.0531 0.338 
AGTC 28.6 35.5 21.3 0.0264 0.123 
GTCT 24.3 26.0 22.4 0.5605 1.000 
ATTC 7.5 5.9 9.3 0.3606 1.000 
GTTC 2.0 1.0 3.1 0.286 0.928 
 GGCC 1.1 1.1 1.1 0.9807 1.000 
Block 2 
GCTCC 40.5 39.4 41.7 0.7357 1.000 
TTCTC 23.2 25.9 20.4 0.3499 1.000 
GTTTT 16.3 15.4 17.2 0.7203 1.000 
GTCTC 9.4 12.5 6.2 0.1227 0.554 
GTTCC 4.0 2.9 5.2 0.4051 1.000 
  GCTTT 2.1 1.0 3.2 0.2701 0.900 
  TTCCC 2.5 1.9 3.1 0.6028 1.000 
 
Haplotypes Total Siblings Controls 
 
Pvalue 
Permutation 
P value 
 
  % % % 
 
 
Block 1 
GTCC 35.5 29.1 42.8 0.0384     0.2250 
AGTC 25.4 29.1 21.4 0.2045     0.9350 
GTCT 28.8 34.5 22.4 0.0543     0.2860 
ATTC 6.8 4.6 9.2 0.1849     0.9030 
GTTC 2.4 1.8 3.1 0.5555 1.000 
Block 2 
GCTCC 43.6 45.3 41.7 0.6008 1.000 
TTCTC 20.6 20.8 20.3 0.9281 1.000 
GTTTT 15.3 13.6 17.2 0.4668 1.000 
GTCTC 10.1 13.6 6.2 0.0765 0.4720 
GTTCC 2.9 1.0 5.1 0.0745 0.4420 
  GCTTT 2.5 1.9 3.2 0.5428 1.000 
 GCCTC 1.5 1.9 1.0 0.6033 1.000 
 TTCCC 1.5 0 3.1 0.0644 0.3600 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Participants demographic, clinical and scale characteristics  
 
Characteristics  Patients Siblings Controls Patients vs. 
Controls 
Patients vs. 
Siblings 
Siblings vs. 
Controls 
Age (years,  MSD)  29.35.9 28.56.8     29.86.3 P=0.695 P=0.554 P=0.335 
Gender (male, %)  59.6 41.8 45.1 P=0.169 P=0.083 P=0.845 
DSM diagnosis (N, %) 
 
Schizophrenia                                                        27 (52%) 
Schizophreniform disorder                                    12 (23%) 
Schizoaffective disorder                                          7 (13%) 
Psychotic disorder NOS                                          6 (12%) 
NA NA    
Age of onset  
(years, MSD)   24.45.1  NA  NA    
Duration of illness  
(months,  MSD)   62.756.7  NA  NA    
 
Scale 
 
Score 
 
 
     
CAPE-P Mean 
SD 
Median 
Range 
1.54 
0.40 
1.45 
1 - 2.85 
1.19 
0.18 
1.15 
1 - 1.80 
1.23 
0.21 
1.20 
1 - 2.30 
 
P<0.001 
 
P<0.001 
 
 
P=0.753 
CAPE-D Mean 
SD 
Median 
Range 
1.85 
0.49 
1.75 
1-3.25 
1.49 
0.28 
1.50 
1-2.75 
1.54 
0.32 
1.50 
1-2.88 
 
P=0.001 
 
P<0.001 
 
P=1.000 
Neuroticism Mean 
SD 
Median 
Range 
13.13 
6.78 
13.00 
1 - 30 
7.89 
4.30 
7.00 
1 – 20 
7.72 
4.58 
6.50 
1 - 19 
 
P<0.001 
 
P<0.001 
 
P = 1.000 
CTQ-total Mean 
SD 
Median 
Range 
1.43 
0.41 
1.28 
1 - 2.72 
1.29 
0.27 
1.18 
1 - 2.20 
1.20 
0.25 
1.12 
1 - 2.24 
 
P=0.003 
 
P=0.264 
 
 P=0.305 
 
Note: NA Non applicable, P<0.05 are presented in bold, Bonferroni adjustment was applied for all analysis 
Table 2. Linear regression analyses: neuroticism as a predictor of subclinical psychotic symptoms  
 
 
Group status 
 
R2 F Coefficient (b)  
(95% CI) 
P value 
 
 
   Neuroticism 
Patients 
 
Siblings 
 
Controls 
0.301 
 
0.252 
 
0.035 
6.322 
 
5.494 
 
0.531 
0.551  (0.121 - 0.329) 
 
0.406  (0.033 - 0.157) 
 
0.183 (-0.031 - 0.129) 
<0.001 
 
  0.003 
 
  0.224 
 
Note: All analyses were adjusted for age and gender, P<0.05 are presented in bold 
 
